DePaul University College of Law, Chicago - March 3, 2008
Date: Monday, March 3, 2008
Time: 7:30 am to 12:30 pm (Light Breakfast will be provided)
Location: DePaul University College of Law, 8th Floor, 1 E. Jackson Blvd., Chicago, IL 60604
CLE Eligible - We have approval for 3 substantive credits for PA, NY and CA, and credit is to be applied for in IL and other jurisdictions.
Cost To Attend: $30 per attendee (You are not required to apply for CLE Credit to attend this symposium)
If you wish to apply for CLE:
Cost CLE Processing: $120 for 3 CLE Credits.
Cost to attend + 3 CLE Credits = $150
Registration: For more information, click here to register or go to www.aplf.org. Any questions regarding this event, contact admin@aplf.org.
Agenda:
The Impact On USA Business of A Changing European Patent Regulatory Environment
DePaul University College of Law, Chicago
“YOUR BUSINESS. YOUR PATENTS. THEIR REGULATIONS”
7:30 - 8:15 am Continental Breakfast
8:15 - 8:30 am
- Welcome — DePaul University College of Law
- Welcome — APLF Vice President (Troy Groetken, Shareholder, McAndrews Held & Malloy Ltd.)
8:30 - 9:30 am
“The Key Aspects Of EPC 2000 And The London Agreement - Practical Outcomes And Cost Saving Ideas For U.S. Practitioners And Companies”
“Added Subject Matter Objections In The EPO.”
Robin Browne — Partner, Leaman Browne (Leeds, UK)
- A business approach to the new Regulations.
9:35 - 11:05 am
“Practical Approaches To Appeals Before The European Patent Office.”
Paul Chapman — Partner, Kilburn & Strode (London, UK)
Dr. Elizabeth Crooks — Kilburn & Strode (London, UK)
- What are the boards of appeal?
- What decisions can be appealed?
- Relationship of BOA’s to Enlarged board
- General procedure/timings
- Oral proceedings
- Special considerations (experts/types of evidence)
11:05 - 11:15 am Break
11:15 - 12:25 pm
“Practical Approaches Of European Oppositions Before The EPO”
Dr. Walter Maiwald — Managing Director, Maiwald Patentanwalts GmbH (Munich, Germany)
- Selecting and preparing evidence
- Using evidence
- Combating the other party’s arguments
- Timing of submissions
- Oral proceedings
- Special considerations concerning appeals
- Rejecting panel members / panels (aka the Art of Harakiri)
12:25 pm Closing Remarks
- APLF Co-President (Howard Bernstein, Sughrue Mion, PLLC.)
Symposium developed with the support of the APLF Law School Program Committee:
Kevin Noonan (McDonnell Boehnen Hulbert & Berghoff LLP); Todd Van Thomme (Price, Heneveld, Cooper, DeWitt & Litton, LLP), James E. Hanft (Darby & Darby P.C), Troy Groetken (McAndrews Held & Malloy Ltd)
The Presenters:
Robin Browne Founding partner Leaman Browne UK rfb@lbpat.com
Robin Browne is a Chartered Patent Attorney and European Patent Attorney. He has more than twenty years’ post qualification experience in many aspects of patent, trademark, design and exploitation matters. His practice has included prosecution and filing of European and national patent applications for a wide variety of clients with particular emphasis on chemical and pharmaceutical subject matter. He has experience of patent and trademark litigation in the UK High Court, Court of Appeal and House of Lords.
Paul Chapman, Senior partner - Kilburn & Strode, a London (UK) pchapman@kstrode.co.uk www.kstrode.co.uk
Paul Chapman is senior partner in the Life Sciences group at Kilburn & Strode, a London (UK) based firm of Patent Attorneys. He is a UK Chartered Patent Attorney and European Patent Attorney and has been practising for over 20 years in the Biotechnology and Pharmaceutical chemistry areas. Paul also spent some time working in house for a major UK pharmaceutical company. Today his practice concentrates on patent drafting and prosecution in the pharmaceutical, biotechnological, drug delivery, diagnostic and medical device fields. In recent years more and more of his time has been spent working with clients on Oppositions and Appeals before the European Patent Office.
Dr. Eliabeth Crooks - Kilburn & Strode, a London (UK) ecrooks@kstrode.co.uk www.kstrode.co.uk
Elizabeth Cook’s practice concentrates on the drafting and prosecution of UK, European and International patent applications in the areas of chemistry (including organic, inorganic and pharmaceutical chemistry) and biochemistry. Her clients include large multinational companies and universities. She works closely with these clients in identifying inventions and proposing patent protection strategies. Elizabeth also advises clients on third party patents, particularly in relation to European oppositions. She obtained a BSc double honours degree in Chemistry and Biochemistry in and a PhD in Bio-Organic Chemistry from the University of Southampton.
Walter Maiwald Dipl.-Chem., Dr. rer. nat, - Maiwald Patentanwalts GmbH in Munich, (Germany) maiwald@maiwald.eu www.maiwald.eu
Dr. Walter Maiwald is the managing director of Maiwald Patentanwalts GmbH in Munich, Germany. His main practice areas include German and international intellectual property law, including patent and trademark prosecution and infringement, litigation, licensing and related consulting services. He has organized and conducted national and international litigation for major clients, in fields ranging from pharmaceuticals to sensor and signal processing technologies. He has successfully represented clients at all court levels in Germany and up to the European Patent Office’s Enlarged Board of Appeal. Walter studied chemistry and English language and literature at the University of Hamburg and at Imperial College, London. He took his German patent bar examination in 1985 and his European patent attorney’s examination in 1987 and is a registered European trademark attorney.
Troy Groetken - Shareholder, McAndrews Held & Malloy Ltd, Chicago tgroetken@mcandrews-ip.com www.mcandrews-ip.com
Troy A. Groetken is a Shareholder with McAndrews Held & Malloy Ltd in Chicago. As a registered patent practitioner, Troy regularly counsels international and Fortune 100 and 500 clients regarding advanced patent prosecution, licensing, complex transactional issues, and global portfolio management matters involving chemical, pharmaceutical and biotechnological matters ranging from new drug (small-molecule, recombinant, combinational technologies, etc.) entities, surfactant technologies, agricultural compositions, gellants, polyols, lubricants, coatings, laundry and cleaning products, pharmaceutical supplements, personal care and cosmetic formulations, alternative fuels, and renewable energies. Prior to practicing patent law, Troy has worked as a clinical consultant pharmacist, supervised drug research programs, evaluated drug management protocols, and performed drug treatment trials on behalf of the FDA. Troy is also the past-President and current Vice-President/Board Member to the Association of Patent Law Firms.
You might also be interested in the following alerts:
- Who We Are
- Exclusions to Patentability
- Patent law updates
- Time Limitations in Pursuit of Damages - UK/Europe
- The impact of adding subject matter before the European Patent Office